nach oben

Journal of Thrombosis and Thrombolysis

Erschienen in:

21.06.2019

A narrative review of red blood cell distribution width as a marker for pulmonary embolism

verfasst von: Lindsay Hammons, Jason Filopei, David Steiger, Eric Bondarsky

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Red blood cell distribution width (RDW) is a marker of variability in red blood cell size, and is routinely reported as part of a patient’s complete blood count. RDW has been shown to be associated with the prediction, severity and prognosis of pulmonary embolism (PE) in recent studies. The underlying biomolecular mechanism of the relationship of RDW to PE is largely unknown, but is thought to be due to the relationship of RDW with acute inflammatory markers and variations in blood viscosity. This review substantiates that a high RDW level, defined using either an arbitrary number or according to receiver operator curve statistics, is associated with a higher risk of acute PE, increased severity (massive vs. submassive) of PE and increased mortality in patients with PE. Nevertheless, the comparison of current studies is limited due to the definition of high RDW (each study uses a different RDW cutoff level), the broad range of exclusion criteria and the inclusion of differing modalities used to diagnose a PE (computed tomography angiogram, ventilation-perfusion study, or clinical diagnosis). Despite the above limitations, these studies provide a promising future clinical use for RDW as a marker of PE.

The pulmonary embolism severity index (PESI) score is a clinical tool that predicts 30-day mortality in those with a PE based on 11 criteria—age, sex, history of cancer, history of heart failure, history of chronic lung disease, heart rate ≥ 110 beats/min systolic blood pressure < 100 mmHg, respiratory rate ≥ 30, temperature < 96.8 °F/36 °C, altered mental status and oxygen saturation < 90%; the algorithm categorizes patients into five groups corresponding to various prognoses, with the highest-scoring groups having the poorest outcome (30-day mortality up to 24.5%) [36]. The simplified PESI (sPESI) is derived from its predecessor and predicts 30-day mortality, but only uses six criteria—age > 80 years, history of cancer, history of chronic cardiopulmonary disease, heart rate ≥ 110 beats/min, systolic blood pressure 9 < 100 mmHg and arterial oxygen saturation < 90% measured at the time of PE diagnosis; each positive variable is assigned 1 point and the patient is then classified into a low-risk (0 points and 1.1% 30-day mortality rate) or high-risk (≥ 1 point[s] and 8.9% 30-day mortality rate) group[59].

The European Society of Cardiology (ESC) also uses a scoring system (including the sPESI score) to classify PE patients into risk groups based on 30-day mortality risk: low (1 point), intermediate (2 points), intermediate-high (3 points) and high (4 points)[38, 60]. For the ESC classification system, one point is allotted to each of the following risk variables: shock/hypotension (systolic blood pressure < 90 mmHg, or a systolic pressure drop by ≥ 50 mmHg for > 15 min), sPESI ≥ 1, RV dysfunction, and troponin T ≥ 14 pg/mL and/or NT-proBNP > 600 pg/mL [38, 60]. The low risk group has a < 1% 30-day mortality, whereas the high risk group has a > 15% 30-day mortality [38].

The Jen scoring system, published in 2018, also predicts 30-day mortality using high-risk variables to define a binary prediction classification (low vs. high risk). There are eight variables, and they are weighted as follows: age in years, HF (+ 20), lung disease (+ 25), respiratory rate > 30 bpm (+ 40), altered mental status (+ 10), IV required (+ 50), ALT > 75 IU/L (+ 40), and hemoptysis (+ 60). Thirty-day mortality risks were 2.1% and 23% for low (score ≤ 100) and high (> 100) risk patients, respectively (p < 0.001) [61].

Stein PD, Beemath A, Olson RE (2005) Trends in the incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients. Am J Cardiol 95(12):1525–1526PubMed

Dalen JE, Alpert JS (1975) Natural history of pulmonary embolism. Prog Cardiovasc Dis 17(4):259–270PubMed

Naess IA, Christiansen SC, Romundstad P et al (2007) Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5(4):692–699PubMed

Watson T, Shantsila E, Lip GY (2009) Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet 373(9658):155–166PubMed

Simel DL, DeLong ER, Feussner JR, Weinberg JB, Crawford J (1988) Erythrocyte anisocytosis: visual inspection of blood films versus automated analysis of red blood cell distribution width. Arch Intern Med 148(4):822–824PubMed

Marsh WL, Bishop JW, Darcy TP (1987) Evaluation of red cell volume distribution width (RDW). Hematol Pathol 1(2):117–123PubMed

Patel KV, Mohanty JG, Kanapuru B et al (2013) Association of the red cell distribution width with red blood cell deformability. Adv Exp Med Biol 765:211–216PubMedPubMedCentral

Lippi GT, Targher G, Montagnana M et al (2009) Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 133(4):628–632PubMed

Sincer I, Zorlu A, Yilmaz M et al (2012) Relationship between red cell distribution width and right ventricular dysfunction in patients with chronic obstructive pulmonary disease. Heart Lung 41(3):238–243PubMed

10.

Oh J, Kang SM, Hong N et al (2009) Relation between red cell distribution width with echocardiographic parameters in patients with acute heart failure. J Card Fail 15(6):517–522PubMed

11.

Tonelli M, Sacks F, Arnold M et al (2008) Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 117(2):163–168PubMed

12.

Felker GM, Allen LA, Pocock SJ et al (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50(1):40–47PubMed

13.

Zorlu A, Bektasoglu G, Guven FM et al (2012) Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism. Am J Cardiol 109(1):128–134PubMed

14.

Gong YL, Long X, Jin J et al (2017) Elevation of red cell distribution width during hospitalization predicts mortality in patients with sepsis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 29(6):481–485PubMed

15.

Otero TMN, Canales C, Yeh DD et al (2016) Elevated red cell distribution width at initiation of critical care is associated with mortality in surgical intensive care unit patients. J Crit Care 34:7–11PubMedPubMedCentral

16.

Makhoul BF, Khourieh A, Kaplan M et al (2013) Relation between changes in red cell distribution width and clinical outcomes in acute decompensated heart failure. Int J Cardiol 167(4):1412–1416PubMed

17.

Kim CH, Park JT, Kim EJ et al (2013) An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock. Crit Care 17(6):R282PubMedPubMedCentral

18.

Zoller B, Melander O, Svensson P, Engstrom G (2014) Red cell distribution width and risk for venous thromboembolism: a population-based cohort study. Thromb Res 133(3):334–339PubMed

19.

Yu FT, Armstrong JK, Tripette J, Meiselman HJ, Cloutier G (2011) A local increase in red blood cell aggregation can trigger deep vein thrombosis: evidence based on quantitative cellular ultrasound imaging. J Thromb Haemost 9(3):481–488PubMedPubMedCentral

20.

Gersh KC, Nagaswami C, Weisel JW (2009) Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes. Thromb Haemost 102(6):1169–1175PubMedPubMedCentral

21.

Celik A, Ozcan IT, Gundes A et al (2015) Usefulness of admission hematologic parameters as diagnostic tools in acute pulmonary embolism. Kaohsiung J Med Sci 31(3):145–149PubMed

22.

Akgedik R, Karamanli H, Kurt AB, Gunaydin ZY (2018) Usefulness of admission red blood cell distribution width as a predictor of severity of acute pulmonary embolism. Clin Respir J 12(2):786–794PubMed

23.

Gunay E, Sarinic Ulasli S, Kacar E et al (2014) Can platelet indices predict obstruction level of pulmonary vascular bed in patients with acute pulmonary embolism? Clin Respir J 8(1):33–40PubMed

24.

Inuzuka R, Abe J (2015) Red blood cell distribution width as a link between ineffective erythropoiesis and chronic inflammation in heart failure. Circ J 79(5):974–975PubMed

25.

Allen LA, Felker GM, Mehra MR et al (2010) Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail 16(3):230–238PubMed

26.

Cha MJ, Lee HS, Kim HM et al (2017) Association between red cell distribution width and thromboembolic events in patients with atrial fibrillation. Eur J Intern Med 46:41–46PubMed

27.

Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G (2015) Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci 52(2):86–105PubMed

28.

Thayer RE, Huang S, Levinson RT et al (2019) Unbiased phenome-wide association studies of red cell distribution width identifies key associations with pulmonary hypertension. Ann Am Thorac Soc. https://doi.org/10.1513/AnnalsATS.201809-594OC CrossRefPubMed

29.

Yardan T, Meric M, Kati C, Celenk Y, Atici AG (2016) Mean platelet volume and mean platelet volume/platelet count ratio in risk stratification of pulmonary embolism. Medicina (Kaunas) 52(2):110–115

30.

Wells PS, Ginsberg JS, Anderson DR et al (1998) Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 129(12):997–1005PubMed

31.

Wicki JP, Perrier A, Perneger TV, Bounameaux H, Junod AF (2000) Prediction adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 84:548–552PubMed

32.

Calisir C, Yavas US, Ozkan IR et al (2009) Performance of the Wells and revised Geneva scores for predicting pulmonary embolism. Eur J Emerg Med 16(1):49–52PubMed

33.

Girardi AM, Bettiol RS, Garcia TS (2018) Wells and Geneva scores are not reliable predictors of pulmonary embolism in critically ill patients: a retrospective study. J Intensive Care Med. https://doi.org/10.1177/0885066618816280 CrossRefPubMed

34.

Singh B, Mommer SK, Erwin PJ, Mascarenhas SS, Parsaik AK (2013) Pulmonary embolism rule-out criteria (PERC) in pulmonary embolism–revisited: a systematic review and meta-analysis. Emerg Med J 30(9):701–706PubMed

35.

Kucher N, Rossi E, DeRosa M, Goldhaber SZ (2006) Massive pulmonary embolism. Circulation 113(4):577–582PubMed

36.

Aujesky D, Obrosky DS, Stone RA et al (2005) Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 172(8):1041–1046PubMedPubMedCentral

37.

Secemsky E, Chang Y, Jain CC et al (2018) Contemporary management and outcomes of patients with massive and submassive pulmonary embolism. Am J Med 131(12):1506–1514PubMed

38.

Torbicki A, Perrier A, Konstantinides S et al (2008) Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J 29(18):2276–2315PubMed

39.

Jaff MR, McMurtry MS, Archer SL et al (2011) Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 123(16):1788–1830PubMed

40.

Inonu H, Acu B, Pazarli AC et al (2012) The value of the computed tomographic obstruction index in the identification of massive pulmonary thromboembolism. Diagn Interv Radiol 18(3):255–260PubMed

41.

Sunnetcioglu A, Sertogullarindan B, Ozbay B, Asker S, Ekin S (2015) Assessments of the associations of thrombus localization with accompanying disorders, risk factors, D-dimer levels, and the red cell distribution width in pulmonary embolism. Clinics 70(6):441–445PubMedPubMedCentral

42.

Bucciarelli P, Maino A, Felicetta I et al (2015) Association between red cell distribution width and risk of venous thromboembolism. Thromb Res 136(3):590–594PubMed

43.

Rahimtoola A, Bergin JD (2005) Acute pulmonary embolism: an update on diagnosis and management. Curr Probl Cardiol 30(2):61–114PubMed

44.

Ozsu S, Abul Y, Gunaydin S, Orem A, Ozlu T (2014) Prognostic value of red cell distribution width in patients with pulmonary embolism. Clin Appl Thromb Hemost 20(4):365–370PubMed

45.

Zhou XY, Chen HL, Ni SS (2017) Red cell distribution width in predicting 30-day mortality in patients with pulmonary embolism. J Crit Care 37:197–201PubMed

46.

Sen HS, Abakay O, Tanrikulu AC et al (2014) Is a complete blood cell count useful in determining the prognosis of pulmonary embolism? Wien Klin Wochenschr 126(11–12):347–354PubMed

47.

Yazici S, Kiris T, Sadik Ceylan U et al (2018) Relation between dynamic change of red cell distribution width and 30-day mortality in patients with acute pulmonary embolism. Clin Respir J 12(3):953–960PubMed

48.

Jurin I, Trkulja V, Ajduk M, Letilović T, Hadžibegović I (2019) Red cell distribution width in acute pulmonary embolism patients: a simple aid for improvement of the 30-day mortality risk stratification based on the pulmonary embolism severity index. Heart Lung. https://doi.org/10.1016/j.hrtlng.2019.02.006 CrossRefPubMed

49.

Kheirkham-Sabetghadam S, Jenab Y, Ghoreyshi-Hefzabad SM et al (2018) Association between elevated red blood cell distribution width and long-term mortality in acute pulmonary embolism. Turk J Med Sci 48(2):318–323PubMed

50.

Yazici S, Siris T, Ceylan US et al (2016) The accuracy of combined use of troponin and red cell distribution width in predicting mortality of patients with acute pulmonary embolism. Wien Klin Wochenschr 128(Suppl 8):596–603PubMed

51.

Condliffe R, Kiely DG, Gibbs JS (2008) Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 177(10):1122–1127PubMed

52.

Witkin AS, Channick RN (2015) Chronic thromboembolic pulmonary hypertension: the end result of pulmonary embolism. Curr Cardiol Rep 17(8):63PubMed

53.

Abul Y, Ozsu S, Korkmaz A et al (2014) Red cell distribution width: a new predictor for chronic thromboembolic pulmonary hypertension after pulmonary embolism. Chronic Respir Dis 11(2):73–81

54.

Wang W, Liu J, Yang YH et al (2016) Red cell distribution width is increased in chronic thromboembolic pulmonary hypertension. Clin Respir J 10(1):54–60PubMed

55.

Forhecz Z, Gombos T, Borgulya G et al (2009) Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 158(4):659–666PubMed

56.

Montagnana M, Cervellin G, Meschi T, Lippi G (2011) The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clin Chem Lab Med 50(4):635–641PubMed

57.

Kato H, Inshida J, Imagawa S et al (2005) Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor. FASEB J 19(14):2023–2025PubMed

58.

Gossmann J, Burkhardt R, Harder S et al (2001) Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway. Kidney Int 60(1):83–86PubMed

59.

Jimenez D, Aujesky D, Moores L et al (2010) Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 170(15):1383–1389PubMed

60.

Konstantinides SV, Torbicki A, Agnelli G et al (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. https://doi.org/10.1093/eurheartj/ehu283 CrossRefPubMedPubMedCentral

61.

Jen WY, Jeon YS, Kojodjojo P (2018) A new model for risk stratification of patients with acute pulmonary embolism. Clin Appl Thromb Hemost. https://doi.org/10.1177/1076029618808922 CrossRefPubMedPubMedCentral

Titel: A narrative review of red blood cell distribution width as a marker for pulmonary embolism
verfasst von: Lindsay Hammons
Jason Filopei
David Steiger
Eric Bondarsky
Publikationsdatum: 21.06.2019
Verlag: Springer US
Erschienen in: Journal of Thrombosis and Thrombolysis / Ausgabe 4/2019
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-019-01906-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Assessment of the reporting quality of RCTs for novel oral anticoagulants in venous thromboembolic disease based on the CONSORT statement

Apixaban: a novel agent to treat heparin induced thrombocytopenia and to prevent embolism in patient with atrial fibrillation after multiple valve replacement?

Assessing patient preferences for switching from warfarin to direct oral anticoagulants

Assessment of preoperative hypercoagulability in patients with pancreatic ductal adenocarcinoma (PDAC) using rapid thromboelastography (r-TEG)

Next generation sequencing in bleeding disorders: two novel variants in the F5 gene (Valencia-1 and Valencia-2) associated with mild factor V deficiency